Indegene (INDGN) | Stock Overview & Key Data
Indegene Performance Comparison
Stock Range
Today's Range
Low: ₹568.25
High: ₹579.50
on August 8, 2025
52 Week Range
Low: ₹499.00
High: ₹736.30
on February 28, 2025
on October 1, 2024
All-Time High: ₹736.30 on September 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR137.1B
EPS
18.08
P/E Ratio (TTM)
31.58
Forward P/E
25.04
P/B Ratio
5.24
PEG Ratio
1.46
Div. Yield
0.34%
ROE
15.55%
Beta
N/A
Debt to Equity
3.88
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
17.57%
Profit Margin
14.89%
Returns and Earnings
Return on Assets (TTM)
12.23%
Return on Equity (TTM)
15.55%
EBITDA
INR6.7B
Net Income (TTM)
INR4.4B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR121.81
Quarterly Revenue Growth (YoY)
12.50%
Quarterly Earnings Growth (YoY)
32.70%
Dividend Information
Last 12-Month Dividend
₹2.00
Current Dividend Yield
0.34%
3-Year Average Dividend Yield
0.34%
3-Year Average Annual Dividend
₹0.67
3-Year Total Dividends
₹2.00
Ex-Dividend Date
June 13, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Indegene INDGN | 137.09B Mid-cap | -1.08% | 1.59% | 4.56% | -7.70% | -5.89% | -0.41% | 2.89% | 2.89% |
| Inventurus Knowledge IKS | 271.31B Large-cap | -0.14% | -0.33% | 7.08% | -5.88% | -17.69% | -15.18% | -15.18% | -15.18% |
| Sagility India SAGILITY | 212.58B Large-cap | 0.51% | 8.63% | 11.17% | -9.64% | -5.70% | 58.51% | 58.51% | 58.51% |
| JSW Steel JSTL | 647.61M Small-cap | 1.05% | -8.69% | -0.10% | -4.29% | -19.31% | -36.50% | -42.89% | 102.51% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | -2.63% | -5.12% | -10.20% | -8.38% | -16.03% | -8.55% | 73.73% | 198.65% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% | 22.45% | 58.73% | 91.42% |
Ownership & Short Interest
Insider Ownership
53.56%
Institutional Ownership
17.96%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
1M
Average 90-Day Volume
591K
Indegene Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Indegene would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is INDGN's 52-week high and low?
- In the last 52 weeks, Indegene reached a high of ₹736.30 (on October 1, 2024) and a low of ₹499.00 (on February 28, 2025).
- What is the market cap and P/E ratio for INDGN?
- Curious about Indegene's size and valuation? Its market capitalization stands at 137.09B. When it comes to valuation, the P/E ratio (trailing twelve months) is 31.58, and the forward P/E (looking ahead) is 25.04.
- Does INDGN pay dividends? If so, what's the yield?
- Yes, Indegene is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.34%, and the company has paid an average of ₹0.67 per share annually over the past 3 years.
- Who are Indegene's main competitors or similar companies to consider before investing?
When looking at Indegene, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Inventurus Knowledge
IKS271.31B Healthcare Health Information Services -15.18% -15.18% Sagility India
SAGILITY212.58B Healthcare Health Information Services 58.51% 58.51% JSW Steel
JSTL647.61M Healthcare Health Information Services -36.50% -42.89% Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -8.55% 73.73% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 22.45% 58.73% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Indegene Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Indegene's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.55%, the Debt to Equity ratio from the most recent quarter is 3.88, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for INDGN?
- Looking at Indegene's growth, its revenue over the trailing twelve months (TTM) was INR29B. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.50%, and quarterly earnings saw a YoY growth of 32.70%.
- How much of INDGN stock is held by insiders and institutions?
- Wondering who owns Indegene stock? Company insiders (like executives and directors) hold about 53.56% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 17.96%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.